OSTEONIC Past Earnings Performance
Past criteria checks 1/6
There is insufficient data on OSTEONIC's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment Industry Growth | 22.7% |
| Revenue growth rate | 32.2% |
| Return on equity | 8.7% |
| Net Margin | 15.6% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How OSTEONIC makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 29,247 | 4,550 | 5,968 | 1,537 |
| 31 Dec 23 | 27,799 | 3,658 | 6,262 | 1,254 |
| 30 Sep 23 | 25,973 | 365 | 5,766 | 586 |
| 30 Jun 23 | 24,342 | -557 | 5,740 | 458 |
| 31 Mar 23 | 22,131 | -276 | 5,455 | 484 |
| 31 Dec 22 | 19,839 | 836 | 4,926 | 454 |
| 30 Sep 22 | 18,116 | 2,345 | 5,760 | 297 |
| 30 Jun 22 | 17,269 | 2,264 | 5,492 | 302 |
| 31 Mar 22 | 16,338 | -70 | 5,629 | 267 |
| 31 Dec 21 | 15,598 | -2,852 | 5,062 | 256 |
Quality Earnings: A226400 has a high level of non-cash earnings.
Growing Profit Margin: A226400 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if A226400's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: A226400 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: A226400 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (4.1%).
Return on Equity
High ROE: A226400's Return on Equity (8.7%) is considered low.